As per the trusted sources of information, in the previous week, when Medtronic put a stop to the production of its HeartWare Heart Ventricular Assist Device pump system.
The company effectively lost USD 1.1 billion on the acquisition of HeartWare International, as they have very little to show for it.Medtronic pulled out the system from the market on Thursday due to the rise in the series of the Class 1 recalls and several increasing reports of the injuries and fatal incidents of the patients.
He further stated that the device is a better option for the patients. He also added that it is a huge decision to make, especially after considering the efforts, blood, and sweat put by them in this therapy over the last six years.However, he added that it is only the right decision that can be taken for the patients.As stated by the FDA, the company had been getting over 100 complaints regarding the failure or the delay of the HVAD pump to restart, along with deaths of 14 patients.
Be First to Comment